Drugs / Kamuvudine K9
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07458061 | Feb → Jun 2026 overdue | diabetic macular edema | Dr. Bryan Strelow | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kamuvudine K9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07458061 ↗ |
| Known as | Kamuvudine-9 | “Kamuvudine-9 (K9) in Diabetic Macular Edema” NCT07458061 ↗ |
| Route | Oral | “oral K9” NCT07458061 ↗ |